Sanofi and GSK to supply US government with 100 million doses of COVID-19 vaccine
|Sanofi and GlaxoSmithKline (GSK) have been selected for "Operation Warp Speed" to supply the United States government with 100 million doses of COVID-19 vaccine, Reuters reported on Friday.
The US government will provide funding up to $2.1 billion for development, including clinical trials and manufacturing scale-up, and delivery of the initial 100 million doses.
Market reaction
The S&P 500 futures edged slightly higher on this headline and were last seen gaining 0.3% on a daily basis. Meanwhile, the US Dollar Index turned positive on the day near 93.00 in the last minutes.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.